Marchex shares surge 16.88% premarket after announcing agreement to acquire Archenia, citing expanded addressable market and AI-driven growth potential.

Marchex Inc. (NASDAQ: MCHX) surged 16.88% in premarket trading following the announcement of its agreement in principle to acquire Archenia, Inc., a performance-based customer acquisition company. The deal, structured as a $10 million convertible promissory note and contingent earnout, is expected to expand Marchex’s addressable market by enabling cross-selling of AI-driven insights and outcome-based solutions. Management highlighted the potential for 10%+ Adjusted EBITDA margins in 2026 and annualized revenue run rates of $60 million, driven by the combined platform’s vertical AI capabilities in healthcare, senior living, and other industries. Additionally, Marchex reported Q3 2025 Adjusted EBITDA of $0.6 million (excluding reorganization costs) and emphasized progress in new product launches, including AI Benchmarking and AgentAI Optimizer, which signaled operational leverage and growth visibility. The acquisition aligns with the company’s strategy to capitalize on AI-driven Pay-Per-Event models, reinforcing investor confidence in long-term scalability.